Pak Fah Yeow International
Pak Fah Yeow International Limited, an investment holding company, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People’s Republic of China, Southeast Asia, North America, the United Kingdom, and internationally. The last earnings update was 149 days ago. More info.
Add to Portfolio Compare Print
239 Share Price and Events
7 Day Returns
1 Year Returns
239 Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Pak Fah Yeow International (239) | 2.3% | 5.9% | 2.3% | -8.1% | -21.1% | 14.8% |
| HK Pharmaceuticals | 4.3% | 15% | -4.9% | -11% | 55.6% | 28.9% |
| HK Market | 1.6% | 6.7% | 6.9% | -11% | 34.7% | 15.6% |
1 Year Return vs Industry and Market
- 239 outperformed the Pharmaceuticals industry which returned -11% over the past year.
- 239 outperformed the Market in Hong Kong which returned -11% over the past year.
239 Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Pak Fah Yeow International
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Pak Fah Yeow International.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Extrapolated from most recent financials. | See below |
| Discount Rate (Cost of Equity) | See below | 8.4% |
| Perpetual Growth Rate | 10-Year HK Government Bond Rate | 2% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year HK Govt Bond Rate | 2% |
| Equity Risk Premium | S&P Global | 8% |
| Pharmaceuticals Unlevered Beta | Simply Wall St/ S&P Global | 0.78 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.776 (1 + (1- 25%) (2.61%)) |
0.791 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.8 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2% + (0.8 * 8%) |
8.4% |
Discounted Cash Flow Calculation for SEHK:239 using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Pak Fah Yeow International is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.
| 2019 | 2020 | 2021 | 2022 | 2023 | |
| Levered FCF (HKD, Millions) | 63.65 | 64.74 | 65.85 | 66.97 | 68.12 |
| Source | Est @ 1.71% | Est @ 1.71% | Est @ 1.71% | Est @ 1.71% | Est @ 1.71% |
|
Present Value Discounted (@ 8.4%) |
58.72 | 55.10 | 51.70 | 48.50 | 45.51 |
| Present value of next 5 years cash flows | HK$259.53 |
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2023
× (1 + g) ÷ (Discount Rate – g)
= HK$68.12 × (1 + 2%) ÷ (8.4% – 2%) |
HK$1,086.10 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)5
= HK$1,086.10 ÷ (1 + 8.4%)5 |
HK$725.62 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 5 years cash flows +
Terminal Value
= HK$259.53 + HK$725.62 |
HK$985.15 |
| Equity Value per Share (HKD) |
= Total value / Shares Outstanding
= HK$985.15 / 311.64 |
HK$3.16 |
| Calculation | Result | |
|---|---|---|
| Value per share (HKD) | From above. | HK$3.16 |
| Current discount | Discount to share price of
HK$3.07
= -1 x (HK$3.07 - HK$3.16) / HK$3.16 |
2.9% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Current Discount
Current Discount Checks
- Pak Fah Yeow International's share price is below the future cash flow value, but not at a moderate discount (< 20%).
- Pak Fah Yeow International's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Pak Fah Yeow International's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Pak Fah Yeow International's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-06-30) in HKD | HK$0.21 |
| SEHK:239 Share Price ** | SEHK (2019-02-15) in HKD | HK$3.07 |
| Hong Kong Pharmaceuticals Industry PE Ratio | Median Figure of 30 Publicly-Listed Pharmaceuticals Companies | 14.33x |
| Hong Kong Market PE Ratio | Median Figure of 1,482 Publicly-Listed Companies | 10.71x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Pak Fah Yeow International.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = SEHK:239 Share Price ÷ EPS (both in HKD) = 3.07 ÷ 0.21 |
14.42x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Pak Fah Yeow International is overvalued based on earnings compared to the HK Pharmaceuticals industry average.
- Pak Fah Yeow International is overvalued based on earnings compared to the Hong Kong market.
Price based on expected Growth
Does
Pak Fah Yeow International's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 14.42x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts |
10.1%per year |
| Hong Kong Pharmaceuticals Industry PEG Ratio | Median Figure of 16 Publicly-Listed Pharmaceuticals Companies | 1.12x |
| Hong Kong Market PEG Ratio | Median Figure of 465 Publicly-Listed Companies | 0.76x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for Pak Fah Yeow International, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Pak Fah Yeow International's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-06-30) in HKD | HK$2.39 |
| SEHK:239 Share Price * | SEHK (2019-02-15) in HKD | HK$3.07 |
| Hong Kong Pharmaceuticals Industry PB Ratio | Median Figure of 34 Publicly-Listed Pharmaceuticals Companies | 1.44x |
| Hong Kong Market PB Ratio | Median Figure of 2,117 Publicly-Listed Companies | 0.97x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = SEHK:239 Share Price ÷ Book Value per Share (both in HKD) = 3.07 ÷ 2.39 |
1.28x |
* Primary Listing of Pak Fah Yeow International.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Pak Fah Yeow International is good value based on assets compared to the HK Pharmaceuticals industry average.
Value checks
We assess Pak Fah Yeow International's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check) Pak Fah Yeow International has a total score of 1/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
239 Future Performance
- No analysts cover Pak Fah Yeow International, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Pak Fah Yeow International's earnings growth is expected to exceed the low risk savings rate of 2%.
Growth vs Market Checks
- Pak Fah Yeow International's earnings growth is positive but not above the Hong Kong market average.
- Unable to compare Pak Fah Yeow International's revenue growth to the Hong Kong market average as no estimate data is available.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| SEHK:239 Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts | 10.1% |
| Hong Kong Pharmaceuticals Industry Earnings Growth Rate | Market Cap Weighted Average | 14.1% |
| Hong Kong Pharmaceuticals Industry Revenue Growth Rate | Market Cap Weighted Average | 15.1% |
| Hong Kong Market Earnings Growth Rate | Market Cap Weighted Average | 11.7% |
| Hong Kong Market Revenue Growth Rate | Market Cap Weighted Average | 10% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (7 months ago) | See Below |
| Future Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
| Date (Data in HKD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-06-30 | 146 | 63 | 66 |
| 2018-03-31 | 163 | 81 | 84 |
| 2017-12-31 | 180 | 99 | 103 |
| 2017-09-30 | 183 | 85 | 104 |
| 2017-06-30 | 186 | 72 | 106 |
| 2017-03-31 | 185 | 69 | 84 |
| 2016-12-31 | 183 | 65 | 61 |
| 2016-09-30 | 176 | 67 | 48 |
| 2016-06-30 | 170 | 69 | 34 |
| 2016-03-31 | 176 | 71 | 48 |
| 2015-12-31 | 183 | 72 | 61 |
| 2015-09-30 | 189 | 72 | 91 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (7 months ago) | See Below |
| Future Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
All data from Pak Fah Yeow International Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in HKD Millions) | EPS * |
|---|---|
| 2018-06-30 | 0.21 |
| 2018-03-31 | 0.27 |
| 2017-12-31 | 0.33 |
| 2017-09-30 | 0.33 |
| 2017-06-30 | 0.34 |
| 2017-03-31 | 0.27 |
| 2016-12-31 | 0.20 |
| 2016-09-30 | 0.15 |
| 2016-06-30 | 0.11 |
| 2016-03-31 | 0.15 |
| 2015-12-31 | 0.20 |
| 2015-09-30 | 0.29 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Unable to establish if Pak Fah Yeow International will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
Future performance checks
We assess Pak Fah Yeow International's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Hong Kong market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Hong Kong market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Pak Fah Yeow International has a total score of 1/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
239 Past Performance
How has Pak Fah Yeow International performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Pak Fah Yeow International's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
- Pak Fah Yeow International's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Pak Fah Yeow International's 1-year earnings growth is negative, it can't be compared to the HK Pharmaceuticals industry average.
Earnings and Revenue History
All data from Pak Fah Yeow International Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in HKD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-06-30 | 146.43 | 66.34 | 32.05 | |
| 2018-03-31 | 163.09 | 84.46 | 32.94 | |
| 2017-12-31 | 179.74 | 102.59 | 33.84 | |
| 2017-09-30 | 183.04 | 104.38 | 32.96 | |
| 2017-06-30 | 186.34 | 106.18 | 32.09 | |
| 2017-03-31 | 184.75 | 83.69 | 31.37 | |
| 2016-12-31 | 183.16 | 61.20 | 30.65 | |
| 2016-09-30 | 176.47 | 47.70 | 31.20 | |
| 2016-06-30 | 169.78 | 34.20 | 31.75 | |
| 2016-03-31 | 176.18 | 47.61 | 32.12 | |
| 2015-12-31 | 182.57 | 61.01 | 32.48 | |
| 2015-09-30 | 188.88 | 91.50 | 33.86 | |
| 2015-06-30 | 195.20 | 121.98 | 35.23 | |
| 2015-03-31 | 191.33 | 134.22 | 34.08 | |
| 2014-12-31 | 187.45 | 146.47 | 32.93 | |
| 2014-09-30 | 175.76 | 121.12 | 31.37 | |
| 2014-06-30 | 164.07 | 95.78 | 29.80 | |
| 2014-03-31 | 163.04 | 83.33 | 29.01 | |
| 2013-12-31 | 162.02 | 70.88 | 28.22 | |
| 2013-09-30 | 148.83 | 68.31 | 26.69 | |
| 2013-06-30 | 135.65 | 65.74 | 25.16 | |
| 2013-03-31 | 132.56 | 65.04 | 24.89 | |
| 2012-12-31 | 129.46 | 64.34 | 24.61 | |
| 2012-09-30 | 129.87 | 55.97 | 24.67 | |
| 2012-06-30 | 130.28 | 47.59 | 24.73 | |
| 2012-03-31 | 123.51 | 46.91 | 24.23 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Pak Fah Yeow International has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Pak Fah Yeow International used its assets more efficiently than the HK Pharmaceuticals industry average last year based on Return on Assets.
- Pak Fah Yeow International's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Pak Fah Yeow International's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Pak Fah Yeow International has a total score of 1/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
239 Health
How is Pak Fah Yeow International's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Pak Fah Yeow International's finances.
The net worth of a company is the difference between its assets and liabilities.
- Pak Fah Yeow International is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Pak Fah Yeow International's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 7.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Pak Fah Yeow International Company Filings, last reported 7 months ago.
| Date (Data in HKD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-06-30 | 745.66 | 24.94 | 148.24 |
| 2018-03-31 | 745.66 | 24.94 | 148.24 |
| 2017-12-31 | 748.51 | 26.66 | 141.83 |
| 2017-09-30 | 748.51 | 26.66 | 141.83 |
| 2017-06-30 | 694.11 | 27.73 | 120.55 |
| 2017-03-31 | 694.11 | 27.73 | 120.55 |
| 2016-12-31 | 633.51 | 27.46 | 89.34 |
| 2016-09-30 | 633.51 | 27.46 | 89.34 |
| 2016-06-30 | 589.43 | 30.36 | 51.67 |
| 2016-03-31 | 589.43 | 30.36 | 51.67 |
| 2015-12-31 | 624.39 | 35.14 | 19.86 |
| 2015-09-30 | 624.39 | 35.14 | 19.86 |
| 2015-06-30 | 615.72 | 37.82 | 47.86 |
| 2015-03-31 | 615.72 | 37.82 | 47.86 |
| 2014-12-31 | 622.63 | 43.76 | 14.96 |
| 2014-09-30 | 622.63 | 43.76 | 14.96 |
| 2014-06-30 | 548.21 | 53.42 | 39.66 |
| 2014-03-31 | 548.21 | 53.42 | 39.66 |
| 2013-12-31 | 516.86 | 49.95 | 16.17 |
| 2013-09-30 | 516.86 | 49.95 | 16.17 |
| 2013-06-30 | 486.05 | 49.47 | 23.70 |
| 2013-03-31 | 486.05 | 49.47 | 23.70 |
| 2012-12-31 | 477.44 | 56.00 | 25.41 |
| 2012-09-30 | 477.44 | 56.00 | 25.41 |
| 2012-06-30 | 414.80 | 56.90 | 28.69 |
| 2012-03-31 | 414.80 | 56.90 | 28.69 |
- Pak Fah Yeow International's level of debt (3.3%) compared to net worth is satisfactory (less than 40%).
- The level of debt compared to net worth has been reduced over the past 5 years (10.2% vs 3.3% today).
- Debt is well covered by operating cash flow (253.6%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 55.1x coverage).
Financial health checks
We assess Pak Fah Yeow International's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Pak Fah Yeow International has a total score of 6/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
239 Dividends
What is Pak Fah Yeow International's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
HK$2,000 of
Pak Fah Yeow International
shares you are expected to receive
HK$82
in your first year as a dividend.
Dividend Amount
- Pak Fah Yeow International's pays a higher dividend yield than the bottom 25% of dividend payers in Hong Kong (2%).
- Pak Fah Yeow International's dividend is below the markets top 25% of dividend payers in Hong Kong (5.51%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
| Hong Kong Pharmaceuticals Industry Average Dividend Yield | Market Cap Weighted Average of 24 Stocks | 1.5% |
| Hong Kong Market Average Dividend Yield | Market Cap Weighted Average of 916 Stocks | 3.5% |
| Hong Kong Minimum Threshold Dividend Yield | 10th Percentile | 1.1% |
| Hong Kong Bottom 25% Dividend Yield | 25th Percentile | 2% |
| Hong Kong Top 25% Dividend Yield | 75th Percentile | 5.5% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in HK$) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2018-04-19 | 0.127 | 3.965 |
| 2017-04-18 | 0.125 | 3.645 |
| 2017-03-27 | 0.125 | 3.534 |
| 2016-04-15 | 0.125 | 3.370 |
| 2016-03-30 | 0.125 | 3.237 |
| 2015-12-15 | 0.202 | 4.976 |
| 2015-09-11 | 0.206 | 5.181 |
| 2015-08-26 | 0.206 | 5.556 |
| 2015-04-16 | 0.179 | 4.355 |
| 2015-03-26 | 0.179 | 4.875 |
| 2014-08-25 | 0.158 | 4.855 |
| 2014-06-25 | 0.155 | 4.728 |
| 2014-04-16 | 0.154 | 5.247 |
| 2014-03-27 | 0.154 | 5.563 |
| 2013-04-17 | 0.109 | 4.252 |
| 2013-03-27 | 0.109 | 4.801 |
| 2012-08-31 | 0.108 | 5.085 |
| 2012-06-28 | 0.103 | 5.137 |
| 2012-03-27 | 0.108 | 5.401 |
| 2011-12-22 | 0.063 | 3.025 |
| 2011-06-28 | 0.077 | 3.624 |
| 2011-03-23 | 0.128 | 5.287 |
| 2010-04-29 | 0.107 | 5.023 |
| 2010-04-22 | 0.107 | 5.841 |
| 2009-09-21 | 0.060 | 4.498 |
| 2009-04-22 | 0.100 | 9.606 |
| 2009-02-16 | 0.043 | 6.299 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Dividends per share have increased over the past 10 years.
Income/ dividend checks
We assess Pak Fah Yeow International's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Pak Fah Yeow International afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Pak Fah Yeow International has a total score of 3/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
239 Management
CEO
| COMPENSATION | HK$6,988,000 |
| AGE | 71 |
| TENURE AS CEO | 7.4 years |
CEO Bio
Mr. Wee Sean Gan has been the Chief Executive Officer of Pak Fah Yeow International Ltd. since September 1, 2011 and serves as its Executive Chairman. Mr. Gan also serves as an Island Command Vice President of the St. John's Ambulance Brigade in Hong Kong. He has been actively involved in the management of Pak Fah Yeow since 1971. He served as Acting Chief Executive Officer of Pak Fah Yeow International Ltd., from April 21, 2008 to September 1, 2011. Mr. Gan has been an Executive Director of Pak Fah Yeow International Ltd. since October 8, 1991. He was the Chairman and Vice Chairman of Chung Sing Benevolent Society from 1987 to 1990 and from 1981 to 1986, respectively. He was the Chairman of the Malaysian Association in Hong Kong from 1987 to 1989 and was a Founder Member of the Institute of Marketing in Hong Kong. Mr. Gan is a Fellow of the Institute of Chartered Secretaries and Administrators and the Chartered Institute of Marketing.
CEO Compensation
- Wee's compensation has been consistent with company performance over the past year.
- Wee's remuneration is higher than average for companies of similar size in Hong Kong.
Management Team
Wee Gan
Executive Chairman & CEO
HK$7M
71
7.4 yrs
Stephen Gan
Executive Director
HK$5M
56
Gavin Gan
Executive Director
HK$975K
37
Gan Eng
Hung Kei Tsang
Chief Financial Officer
47
Tai On Lo
Company Secretary
64
10.1 yrs
Lai Ching Yau
COO & Executive Director of Hoe Hin Pak Fah Yeow Manufactory Ltd
53
Anthony Tang
Head of Sales & Marketing of Hoe Hin Pak Fah Yeow Manufactory Limited
56
Board of Directors Tenure
Average tenure and age of the Pak Fah Yeow International board of directors in years:
- The average tenure for the Pak Fah Yeow International board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors
Wee Gan
Executive Chairman & CEO
HK$7M
71
Stephen Gan
Executive Director
HK$5M
56
Gavin Gan
Executive Director
HK$975K
37
3.4 yrs
Lai Ching Yau
COO & Executive Director of Hoe Hin Pak Fah Yeow Manufactory Ltd
53
Lawrence Leung
Independent Non-Executive Director
HK$124K
70
12.6 yrs
Ada Wong
Independent Non Executive Director
HK$124K
58
14.4 yrs
Arnold Ip
Independent Non Executive Director
HK$124K
55
14.4 yrs
Anita Gan
Non-Executive Director
HK$124K
50
3.4 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (HK$) | Value (HK$) | |
|---|---|---|---|---|---|---|---|---|---|---|
Management checks
We assess Pak Fah Yeow International's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Pak Fah Yeow International has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
239 News
Simply Wall St News
How Much is Pak Fah Yeow International Limited's (HKG:239) CEO Getting Paid?
Wee Gan became the CEO of Pak Fah Yeow International Limited (HKG:239) in 2011. … This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … How Does Wee Gan's Compensation Compare With Similar Sized Companies?
Simply Wall St - – Full articleWhat Kind Of Shareholder Owns Most Pak Fah Yeow International Limited (HKG:239) Stock?
Every investor in Pak Fah Yeow International Limited (HKG:239) should be aware of the most powerful shareholder groups. … Pak Fah Yeow International is not a large company by global standards. … See our latest analysis for Pak Fah Yeow International
Simply Wall St - – Full articleIs Pak Fah Yeow International Limited (HKG:239) An Attractive Dividend Stock?
Historically, Pak Fah Yeow International Limited (HKG:239) has paid dividends to shareholders, and these days it yields 4.3%. … Does Pak Fah Yeow International tick all the boxes of a great dividend stock? … Check out our latest analysis for Pak Fah Yeow International
Simply Wall St - – Full articleA Closer Look At Pak Fah Yeow International Limited's (HKG:239) Uninspiring ROE
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. … Our data shows Pak Fah Yeow International has a return on equity of 8.9% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleDo You Like Pak Fah Yeow International Limited (HKG:239) At This P/E Ratio?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). … We'll look at Pak Fah Yeow International Limited's (HKG:239) P/E ratio and reflect on what it tells us about the company's share price. … Pak Fah Yeow International has a price to earnings ratio of 14.52, based on the last twelve months.
Simply Wall St - – Full articleDoes Pak Fah Yeow International Limited's (HKG:239) CEO Pay Compare Well With Peers?
First, this article will compare CEO compensation with compensation at similar sized companies. … How Does Wee Gan's Compensation Compare With Similar Sized Companies. … According to our data, Pak Fah Yeow International Limited has a market capitalization of HK$938m, and pays its CEO total annual compensation worth HK$7m.
Simply Wall St - – Full articleShould You Buy Pak Fah Yeow International Limited (HKG:239) For Its Dividend?
A large part of investment returns can be generated by dividend-paying stock given their role in compounding returns over time. … Historically, Pak Fah Yeow International Limited (HKG:239) has paid dividends to shareholders, and these days it yields 4.0%. … Let's dig deeper into whether Pak Fah Yeow International should have a place in your portfolio.
Simply Wall St - – Full articleInterested In Pak Fah Yeow International Limited (HKG:239)’s Upcoming HK$0.078 Dividend? You Have 2 Days Left
Important news for shareholders and potential investors in Pak Fah Yeow International Limited (HKG:239): The dividend payment of HK$0.078 per share will be distributed into shareholder on 17 August 2018, and the stock will begin trading ex-dividend at an earlier date, 09 July 2018. … Investors looking for higher income-generating stocks to add to their portfolio should keep reading, as I take a deeper dive into Pak Fah Yeow International's latest financial data to analyse its dividend attributes. … When assessing a stock as a potential addition to my dividend Portfolio, I look at these five areas:
Simply Wall St - – Full articleShould Pak Fah Yeow International Limited (HKG:239) Be Your Next Stock Pick?
As an investor, I look for investments which does not compromise one fundamental factor for another. … By this I mean, I look at stocks holistically, from their financial health to their future outlook. … is a company with great financial health as well as a.
Simply Wall St - – Full articleIs Pak Fah Yeow International Limited (HKG:239) A Financially Sound Company?
How does 239’s operating cash flow stack up against its debt? … Moreover, 239 has produced cash from operations of HK$65.42M over the same time period, resulting in an operating cash to total debt ratio of 238.22%, meaning that 239’s debt is appropriately covered by operating cash. … In 239's, case, the ratio of 100x suggests that interest is comfortably covered, which means that lenders may be inclined to lend more money to the company, as it is seen as safe in terms of payback.Next Steps: 239’s high cash coverage and low debt levels indicate its ability to utilise its borrowings efficiently in order to generate ample cash flow.
Simply Wall St - – Full article239 Company Info
Map
Description
Pak Fah Yeow International Limited, an investment holding company, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People’s Republic of China, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers Hoe Hin White Flower Embrocation or Hoe Hin Pak Fah Yeow, a medicated oil; Hoe Hin Strain Relief; and Hoe Hin White Flower ointment products, as well as Fúzai 239, a floral-scented White Flower Embrocation. It also provides advertising agency services. Pak Fah Yeow International Limited is headquartered in Wan Chai, Hong Kong.
Details
| Name: | Pak Fah Yeow International Limited |
| 239 | |
| Exchange: | SEHK |
| Founded: | |
| HK$956,734,800 | |
| 311,640,000 | |
| Website: | http://www.whiteflower.com |
| Address: |
Pak Fah Yeow International Limited 200 Gloucester Road, 11th Floor, Wan Chai, Hong Kong |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| SEHK | 239 | Ordinary Shares | The Stock Exchange of Hong Kong Ltd. | HK | HKD | 15. Sep 1992 |
Number of employees
Current staff
Industry
| Pharmaceuticals | |
| Pharmaceuticals & Biotech |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/02/15 12:46 |
| End of day share price update: | 2019/02/15 00:00 |
| Last earnings filing: | 2018/09/19 |
| Last earnings reported: | 2018/06/30 |
| Last annual earnings reported: | 2017/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
